THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Hybrid journal

Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SCIE), Scopus
Impact Factor 1.3 (2023)

Quarterly

pISSN 1824-4785

eISSN 1827-1936

Aims and scope

The Quarterly Journal of Nuclear Medicine and Molecular Imaging, a quarterly international, peer-reviewed scientific journal on Nuclear Medicine and Molecular Imaging, indexed in Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SCIE), Scopus, has an impact factor of 1.560.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging is affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging publishes scientific papers on clinical and experimental topics of nuclear medicine.
Since its first publication in 1957, the journal has been dedicated to publishing articles pertaining to current diagnostic and therapeutic news in the field of nuclear medicine as well as guidance on emerging techniques and technologies.
Manuscripts may be submitted in the form of editorials, original articles, review articles and special articles.
The journal aims to provide its readers with papers of the highest quality and impact through a process of careful peer review and editorial work.
The Journal offers a fast and rigorous peer review process as well as open access options.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging welcomes articles on a wide variety of topics related to nuclear medicine.

Chief Editor
Gianni Bisi
University of Turin, Turin, Italy